News

(English) Chime Biologics and Korean Listed Company MedPacto Form Strategic Partnership to Accelerate Global Biologics Development and Manufacturing

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics and Korean Listed Company MedPacto Form Strategic Partnership to Accelerate Global Biologics Development and Manufacturing October 28, 2024, Shanghai, […]

(English) Chime Biologics congratulates Hope Medicine on HMI-115’s CDE Breakthrough Therapy Designation

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics congratulates Hope Medicine on HMI-115’s CDE Breakthrough Therapy Designation Not available.

(English) Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics SEATTLE, Oct. 9, 2024 /PRNewswire/ — Arbele, a leading innovator […]

(English) Chime Biologics Successfully Hosts Fuel BioGrowth Chime Day 2024 Event

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics Successfully Hosts Fuel BioGrowth Chime Day 2024 Event September 30, 2024, Wuhan – Chime Biologics, a leading global CDMO […]

(English) Chime Biologics won two awards at the Asia Pacific Biologics CMO Excellence Awards 2024

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics won two awards at the Asia Pacific Biologics CMO Excellence Awards 2024 Recently, at the 3rd Biologics Contract Manufacturing […]

(English) pilot-plant-of-chime-biologics

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.  pilot-plant-of-chime-biologics No content available

(English) Going Global – Chime Biologics Embraces Innovation and Quality with Partners

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Going Global-Chime Biologics Embraces Innovation and Quality with Partners Foreign biopharmaceutical companies seek CDMO partners with long-term prospects, technology levels, and […]

(English) Domain Therapeutics and Chime Biologics announce manufacturing agreement to advance novel anti-CCR8 antibody for cancer immunotherapy

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Domain Therapeutics and Chime Biologics announce manufacturing agreement to advance novel anti-CCR8 antibody for cancer immunotherapy The agreement combines Domain Therapeutics’ […]

(English) Chime Biologics Achieves ISO 27001 Certification to Strengthen Information Security in the CDMO Industry

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics Achieves ISO 27001 Certification to Strengthen Information Security in the CDMO Industry March 7, 2024, Wuhan, China – Chime […]

(English) Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and […]

categoryidArraymk-test